Dr. Aurélie Plessier is a French hepatologist and consultant in the Hepatology Unit at Beaujon Hospital (Clichy, France), where she has been leading the National Referral Centre for Vascular Liver Diseases (CRMVF) since 2006.

Dr. Wong is a full professor at the University of Toronto. She has spent her career researching on the pathophysiology of decompensated cirrhosis, especially on ascites and renal failure. More recently, she has extended her research into acute-on-chronic liver failure, concentrating on understanding organ failures and potential treatment

Dr. Raiya Sarwar is an Assistant Professor of Medicine at NYU Langone, specializing in living donor liver transplantation, metabolic associated steatotic liver disease, alcohol-related liver disease, and autoimmune liver conditions. She is board-certified in internal medicine, gastroenterology, and transplant hepatology. Dr. Sarwar is an active member of the AASLD Surgery and Transplantation Committee. She completed her medical degree at Rawalpindi Medical College, followed by residency at the University of Illinois–Urbana Champaign and fellowship at the University of Minnesota.

Dr. Thomas D. Schiano is Professor of Medicine in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai, and is the Medical Director of the Adult Liver Transplant program, Director of Clinical Hepatology, Medical Director of Intestinal Transplantation, and Medical Director of VCA Transplantation at the Recanati/Miller Transplant Institute at the Mount Sinai Medical Center.

Dr. Green's expertise includes regulation of gene transcription and lipid metabolism in the context of metabolic disease and cancer. His expertise focuses on understanding how Western diet-induced changes in metabolism, particularly sphingolipids, contribute to the development of obesity-related metabolic disease and cancer.

My laboratory will focus on understanding liver metabolism in normal and diseased states. Our goal is to investigate how bile acids and nuclear receptors maintain metabolic homeostasis and contribute to liver diseases, including cancer, using cell-based systems and genetically engineered mouse models.<br><br>

Dr. Jessica Hartman is a tenure-track Assistant Professor in the Department of Biochemistry and Molecular Biology and the Department of Regenerative Medicine at the Medical University of South Carolina. Dr. Hartman completed her Ph.D. with the support of a NSF GRFP fellowship at the University of Arkansas for Medical Sciences in the lab of Dr. Grover Miller studying enzyme kinetics of substrate oxidation by cytochrome P450 2E1 (CYP2E1). She then went on to do a NIEHS F32-supported postdoctoral fellowship with Dr.